IL-15: a central regulator of celiac disease immunopathology. - Wikidata - wikimedia - TriplyDB

IL-15: a central regulator of celiac disease immunopathology.

IL-15: a central regulator of celiac disease immunopathology.

http://www.wikidata.org/entity/Q33788829

about

Role of the intestinal cytokine microenvironment in shaping the intraepithelial lymphocyte repertoire Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.Mucosal inflammation, esophageal eosinophilia, and celiac disease: a little "pinch" will have to do you.Does the microbiota play a role in the pathogenesis of autoimmune diseases?Innate immunity: actuating the gears of celiac disease pathogenesis Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease.Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease.Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis.Immunopathogenesis of olmesartan-associated enteropathy.Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714MuXHu in cynomolgus monkeys.Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques Tailored immunity at mucosae.Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy.IL-15 sustains IL-7R-independent ILC2 and ILC3 development.Lessons from rodent models in celiac disease.The chemokine CCL28 is elevated in the serum of patients with celiac disease and decreased after treatment.Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.Immunopathogenesis and therapeutic approaches in pediatric celiac disease.Non Celiac Gluten Sensitivity.CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes Physiopathology and Management of Gluten-Induced Celiac Disease.Norovirus infection in primary immune deficiency.Oral nucleic acid therapy using multicompartmental delivery systems.Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad.Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques.Mechanisms of innate immune activation by gluten peptide p31-43 in mice.Prevalence of celiac disease in patients with severe food allergy.Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea.Is adaptive-innate lymphocyte cross-talk driving mucosal disease?Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease.How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation.Intestinal overexpression of interleukin (IL)-15 promotes tissue eosinophilia and goblet cell hyperplasia.Peptides as Therapeutic Agents for Inflammatory-Related Diseases

P2860

Q28085758-42D8A227-AB95-4146-9CED-3B4061C8DB93 Q34447313-8D028AFA-8773-46CD-9B80-523DD72701FC Q35236440-3EF22148-2841-467E-A0CB-E3307A63D3BD Q35443254-675D9B22-A0E1-45A5-994A-09683C93F86F Q35733419-FDA24DBA-DA9D-4F71-88FA-838534C162F7 Q35998352-969C37E9-DBDC-4CCD-854A-21E4A9B2D7FE Q36027518-B0772DFF-D49B-47AC-8780-447BA302F897 Q36080707-C6E1B24D-66A7-457D-B4DB-D0FE33DDF284 Q36096978-230B8AC0-49A3-4E4D-AC22-EA22AD949D56 Q36225350-A6089435-F7D0-4933-8F7C-67DB0E3D2234 Q36648845-D92C3857-68C9-4F37-9EC7-5D3E99EAC8DD Q37133010-477F63EF-E54D-45CF-95F4-5935D0A6539B Q37157676-F0249AAB-5BB8-492F-ACD3-BBD40CFA5DAE Q37230849-AE5DE08C-FAFA-4E64-BED2-C7F4CC2ACFCF Q37364736-2B308850-D7E9-43EF-B22F-CC8BD7AFF96F Q37588429-7E505586-34C3-4D7C-8E01-62A6696AACAD Q37737853-6422F3F3-F995-44B4-B396-C37A6810EED5 Q38263650-C0B76A3A-C4B7-4717-A898-ED05DDA9BAE1 Q38685047-6B4A5019-94D2-40BC-8737-C0E4EE7DB92D Q38743690-FD80E6FF-A530-4E03-AC89-740B5EB81649 Q38783192-9FC257CB-AA52-4341-9444-5B9142CF59D4 Q38982195-8588474C-286F-49DB-97CF-2C284E410861 Q39042122-53365157-E406-400F-95F4-C707C02A652C Q39111493-015400FD-AF0C-425F-B010-C12C3ECF6BAC Q39167685-DA305756-922C-4AAB-BB63-AFEDDA89EF16 Q39330117-C2579A98-B387-4EAC-9402-974A09445886 Q39428969-215C756A-52B0-4E10-B36A-3DCF8EB0CA40 Q40645100-E91D7C3B-2C5B-4606-8E1A-3BB018D7996C Q40685138-EE9EB4B7-A133-4861-AC3B-9BBD93825ADE Q40731479-CF59B02F-E2C9-4490-A0BC-63A55ED6FA4F Q41348755-A0A826E3-0D6E-486A-80CA-F9C539CD312D Q41546077-AF7F3AAB-806C-4D56-A078-8D5891160314 Q42321765-E23547E3-E9A9-4283-85C2-F5413735BB70 Q46487529-05FAFC6C-7432-47B4-8B0F-C7CBEE318720 Q47104884-8526AC07-D69F-4416-AC33-3F4A1F969AE6 Q47161100-578FD7A1-806E-4624-8960-20B36D28AD0C Q48178759-0A22260F-8DCA-43C4-8B7A-E01EADA85200 Q58749714-4D3AE101-0C73-4223-AEB1-ADED7E7B029E

P2860

IL-15: a central regulator of celiac disease immunopathology.

http://www.wikidata.org/entity/Q33788829

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

IL-15: a central regulator of celiac disease immunopathology.

@ast

IL-15: a central regulator of celiac disease immunopathology.

@en

type

label

IL-15: a central regulator of celiac disease immunopathology.

@ast

IL-15: a central regulator of celiac disease immunopathology.

@en

prefLabel

IL-15: a central regulator of celiac disease immunopathology.

@ast

IL-15: a central regulator of celiac disease immunopathology.

@en

P1433

Q33788829-68BB3826-5BAA-48A7-A9A7-38B8F67A4CD4

P1476

Q33788829-054C6D6B-4261-4F36-B724-633B7EA09F79

P2093

Q33788829-D26B1890-B472-4310-8B90-B0C8ED378940

Q33788829-F2D2F6AE-A78F-41D6-82E4-8AF0D2253E32

P2860

Q33788829-0154A0F7-7E6B-413A-8712-669876C0D154

Q33788829-01CB4268-749A-41D2-A4B7-D7AB4A95B09D

Q33788829-01EDF6D5-DDB2-491C-8108-A36C812386CB

Q33788829-04AABEE4-C7F3-4A58-B5F4-199397C8CFC6

Q33788829-05BF3720-E968-4998-B282-E94D773BB4FA

Q33788829-076CB978-34D1-444A-B599-E464EA6B19EB

Q33788829-0983B3C1-C193-4485-875C-155336C45FC7

Q33788829-09EDDC19-1408-476D-BDD0-642F3D21F707

Q33788829-0B55507C-F7B4-44F9-B81B-226247FCA35C

Q33788829-0B6EEDC4-A8F2-43DA-A552-0DF207E30B15

P304

Q33788829-D6E400A2-E566-41A2-9589-9FBC03964616

P31

Q33788829-EA5297FF-67D7-4EB3-9893-F54EABEC32EC

P356

Q33788829-15916A3D-C9FA-46FA-82B7-0A7087DCFBCF

P433

Q33788829-18610A5B-AA8E-4091-95BE-07E9E1BB1A8C

P478

Q33788829-E0F1F8C1-F356-495C-B2F9-C9319A63B8FF

P577

Q33788829-57050403-6FA9-4AD7-879D-8C292C90E648

P698

Q33788829-D85C19A0-7851-41A1-B724-7FD49052D36B

P932

Q33788829-095B2640-727D-439D-8F8A-D19B3ED150C0

P356

P1433

Immunological Reviews

P1476

IL-15: a central regulator of celiac disease immunopathology.

@en

P2093

Bana Jabri

http://www.w3.org/2001/XMLSchema#string

Valérie Abadie

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15

Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor

Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation

Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience

Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation

Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15

The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

P304

221-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IMR.12191

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

260

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24942692

http://www.w3.org/2001/XMLSchema#string

P932

4066219

http://www.w3.org/2001/XMLSchema#string